chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Muscular weakness
Clinical narrative: migraine; headache; slurred speech; hands were numb; droopy eyes; couldn't use hands properly; This spontaneous case was reported by a consumer and describes the occurrence of DYSARTHRIA (slurred speech), HYPOAESTHESIA (hands were numb), ASTHENOPIA (droopy eyes), MUSCULAR WEAKNESS (couldn't use hands properly) and MIGRAINE (migraine) in a 19-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Migraine.    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced DYSARTHRIA (slurred speech), HYPOAESTHESIA (hands were numb), ASTHENOPIA (droopy eyes), MUSCULAR WEAKNESS (couldn't use hands properly) and HEADACHE (headache). On an unknown date, the patient experienced MIGRAINE (migraine). At the time of the report, DYSARTHRIA (slurred speech), HYPOAESTHESIA (hands were numb), ASTHENOPIA (droopy eyes), MUSCULAR WEAKNESS (couldn't use hands properly), MIGRAINE (migraine) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not provided. Treatment information was not provided.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Myalgia, Vaccination site pain
Clinical narrative: Fatigue; severe headache; phantom pain in right deltoid at injection site.; Achy-type pain\ phantom pain in right deltoid at injection site; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue), HEADACHE (severe headache), VACCINATION SITE PAIN (phantom pain in right deltoid at injection site.) and MYALGIA (Achy-type pain\ phantom pain in right deltoid at injection site) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031B21A and 002B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 09-Apr-2021, the patient experienced FATIGUE (Fatigue), HEADACHE (severe headache), VACCINATION SITE PAIN (phantom pain in right deltoid at injection site.) and MYALGIA (Achy-type pain\ phantom pain in right deltoid at injection site). At the time of the report, FATIGUE (Fatigue), HEADACHE (severe headache), VACCINATION SITE PAIN (phantom pain in right deltoid at injection site.) and MYALGIA (Achy-type pain\ phantom pain in right deltoid at injection site) outcome was unknown. Not Provided          Concomitant medication was not provided Treatment information was not provided  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable   Most recent FOLLOW-UP information incorporated above includes: On 17-May-2021: updated event verbatim:
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased
Clinical narrative: Since 05Apr2021 her blood pressure has gone steadily up; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD PRESSURE INCREASED (Since 05Apr2021 her blood pressure has gone steadily up) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 vaccination.     The patient's past medical history included Rheumatoid arthritis. Concurrent medical conditions included Hypertension (was under control). Concomitant products included METHOTREXATE for Rheumatoid arthritis, FISH OIL, METAXALONE, ACETYLSALICYLIC ACID (BABY ASPIRIN), CLOPIDOGREL BISULFATE (PLAVIX), PANTOPRAZOLE SODIUM SESQUIHYDRATE (PROTONIX [PANTOPRAZOLE SODIUM SESQUIHYDRATE]), FOLIC ACID, LORATADINE, PREGABALIN (LYRICA), LISINOPRIL, SPIRONOLACTONE, VORTIOXETINE, PRAMIPEXOLE, CLONIDINE and METOPROLOL TARTRATE for an unknown indication, METOPROLOL TARTRATE (LOPRESSOR).    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, the patient experienced BLOOD PRESSURE INCREASED (Since 05Apr2021 her blood pressure has gone steadily up). At the time of the report, BLOOD PRESSURE INCREASED (Since 05Apr2021 her blood pressure has gone steadily up) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment included Clonidine. Patient informed that she does not have any events after second dose on 21-April- 2021   Most recent FOLLOW-UP information incorporated above includes: On 17-May-2021: follow up received on 17-may-2021 contains information about medical history, concomitant medication and second dose details
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Acne, Biopsy, Computerised tomogram, Fatigue, Menstruation irregular
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), ACNE (acne on her face), MENSTRUATION IRREGULAR (she started her period after 7 years of being in menopause) and FATIGUE (tired) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination. No Medical History information was reported. On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm) and FATIGUE (tired). On 18-Mar-2021, the patient experienced ACNE (acne on her face). On 19-Mar-2021, the patient experienced MENSTRUATION IRREGULAR (she started her period after 7 years of being in menopause). On 13-Mar-2021, PAIN IN EXTREMITY (sore arm) and FATIGUE (tired) had resolved. On 19-Mar-2021, ACNE (acne on her face) had resolved. On 02-Apr-2021, MENSTRUATION IRREGULAR (she started her period after 7 years of being in menopause) had resolved. Not Provided. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Biopsy: normal (normal) came back normal. On an unknown date, Computerised tomogram: abnormal (abnormal) thickened uterine wall consistent with menstruation. On an unknown date, Ultrasound scan: abnormal (abnormal) Thickened uterine wall consistent with menstruation. mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged. Concomitant medications were not provided. Treatment information was not provided by reporter. This case was linked to MOD-2021-074747.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Ultrasound scan
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), ACNE (acne on her face), MENSTRUATION IRREGULAR (she started her period after 7 years of being in menopause) and FATIGUE (tired) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination. No Medical History information was reported. On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm) and FATIGUE (tired). On 18-Mar-2021, the patient experienced ACNE (acne on her face). On 19-Mar-2021, the patient experienced MENSTRUATION IRREGULAR (she started her period after 7 years of being in menopause). On 13-Mar-2021, PAIN IN EXTREMITY (sore arm) and FATIGUE (tired) had resolved. On 19-Mar-2021, ACNE (acne on her face) had resolved. On 02-Apr-2021, MENSTRUATION IRREGULAR (she started her period after 7 years of being in menopause) had resolved. Not Provided. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Biopsy: normal (normal) came back normal. On an unknown date, Computerised tomogram: abnormal (abnormal) thickened uterine wall consistent with menstruation. On an unknown date, Ultrasound scan: abnormal (abnormal) Thickened uterine wall consistent with menstruation. mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged. Concomitant medications were not provided. Treatment information was not provided by reporter. This case was linked to MOD-2021-074747.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Headache, Pain in extremity, Pruritus
Clinical narrative: itchy in her legs,itchy in her shin,itchy in her arm between the breasts and elbows; tired; dizzied; headache; little sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (little sore arm), PRURITUS (itchy in her legs,itchy in her shin,itchy in her arm between the breasts and elbows), DIZZINESS (dizzied), HEADACHE (headache) and FATIGUE (tired) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030B21A and 044A21A) for COVID-19 vaccination.     Concurrent medical conditions included Cancer. Concomitant products included LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) and FOLIC ACID for an unknown indication.   On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On 09-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PAIN IN EXTREMITY (little sore arm). On 10-Apr-2021, the patient experienced DIZZINESS (dizzied) and HEADACHE (headache). On 11-Apr-2021, the patient experienced FATIGUE (tired). On an unknown date, the patient experienced PRURITUS (itchy in her legs,itchy in her shin,itchy in her arm between the breasts and elbows). At the time of the report, PAIN IN EXTREMITY (little sore arm), PRURITUS (itchy in her legs,itchy in her shin,itchy in her arm between the breasts and elbows), DIZZINESS (dizzied), HEADACHE (headache) and FATIGUE (tired) outcome was unknown.            Treatment information included for cancer treatment
Sex: F
Vaccine: COVID19
Symptoms: Underdose
Clinical narrative: While getting vaccinated she noticed there was some dose left in the syringe; This spontaneous case was reported by a consumer and describes the occurrence of UNDERDOSE (While getting vaccinated she noticed there was some dose left in the syringe) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, the patient experienced UNDERDOSE (While getting vaccinated she noticed there was some dose left in the syringe). On 07-Apr-2021, UNDERDOSE (While getting vaccinated she noticed there was some dose left in the syringe) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.   The patient believed that she did not get the full dose of the vaccine.   Treatment information was not provided.  Action taken with mRNA-1273 in response to the event was unknown
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Dysuria, Fatigue, Pyrexia
Clinical narrative: Difficulty to pee; High Fever; Very tired; This spontaneous case was reported by a consumer and describes the occurrence of DYSURIA (Difficulty to pee), PYREXIA (High Fever) and FATIGUE (Very tired) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037B21A) for COVID-19 vaccination.     Concurrent medical conditions included Cardiac disorder (on medications.).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DYSURIA (Difficulty to pee), PYREXIA (High Fever) and FATIGUE (Very tired). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, DYSURIA (Difficulty to pee), PYREXIA (High Fever) and FATIGUE (Very tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient was on unspecified medications.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Dizziness, Nausea
Clinical narrative: chills; Diarrhea; Dizziness; nausea; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), DIARRHOEA (Diarrhea), DIZZINESS (Dizziness) and NAUSEA (nausea) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included AMLODIPINE, CARVEDILOL, FUROSEMIDE, MAGNESIUM, MONTELUKAST and POTASSIUM for an unknown indication.    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, the patient experienced CHILLS (chills), DIARRHOEA (Diarrhea), DIZZINESS (Dizziness) and NAUSEA (nausea). At the time of the report, CHILLS (chills), DIARRHOEA (Diarrhea), DIZZINESS (Dizziness) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster, Pruritus
Clinical narrative: Crazy itching; Shingles started on Wednesday, but was really bad on Saturday and sunday; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Shingles started on Wednesday, but was really bad on Saturday and sunday) and PRURITUS (Crazy itching) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A 4/10/63) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, the patient experienced HERPES ZOSTER (Shingles started on Wednesday, but was really bad on Saturday and sunday). On 10-Apr-2021, the patient experienced PRURITUS (Crazy itching). At the time of the report, HERPES ZOSTER (Shingles started on Wednesday, but was really bad on Saturday and sunday) and PRURITUS (Crazy itching) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient received anti-viral and a cream as a treatment. No concomitant medications were reported.
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: not able to find an appointment for second shot and he has missed the window; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (not able to find an appointment for second shot and he has missed the window) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (not able to find an appointment for second shot and he has missed the window). At the time of the report, PRODUCT DOSE OMISSION ISSUE (not able to find an appointment for second shot and he has missed the window) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided. Action taken with mRNA-1273 in response to the event was unknown
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Myalgia, Pyrexia
Clinical narrative: Had 30-45 minutes of shortness of breath; Fever; Muscle aches; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Had 30-45 minutes of shortness of breath), PYREXIA (Fever) and MYALGIA (Muscle aches ) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042B21A and 044A21A) for COVID-19 vaccination.     Concurrent medical conditions included Shortness of breath (pre-existing medical condition that also causes similar shortness of breath).   On 14-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Apr-2021, the patient experienced DYSPNOEA (Had 30-45 minutes of shortness of breath), PYREXIA (Fever) and MYALGIA (Muscle aches ). On 12-Apr-2021, DYSPNOEA (Had 30-45 minutes of shortness of breath) had resolved. At the time of the report, PYREXIA (Fever) and MYALGIA (Muscle aches ) outcome was unknown.            Concomitant product use was not reported.  Treatment information included acetaminophen to help with the fever and muscle aches.  The patient received both scheduled doses of mRNA-1273 prior to the event(s); therefore, action taken with the drug in response to the event(s) is not applicable.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore arm) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, the patient experienced VACCINATION SITE PAIN (sore arm). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PAIN (sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant  medications were reported.  Treatment medicines include Tylenol  Action taken with mRNA-1273 in response to the event was unknown   This case was linked to US-MODERNATX, INC.-MOD-2021-074739 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Feeling abnormal, Gait disturbance, Inflammation, Joint swelling
Clinical narrative: Hip is so inflamed; She could hardly walk; Felt terrible; Right hip is so inflamed; Pain in hip; Little sore arm; This spontaneous case was reported by a consumer and describes the occurrence of JOINT SWELLING (Hip is so inflamed), GAIT DISTURBANCE (She could hardly walk), FEELING ABNORMAL (Felt terrible), INFLAMMATION (Right hip is so inflamed) and PAIN IN EXTREMITY (Little sore arm) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029A21A and 042L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In February 2021, the patient experienced PAIN IN EXTREMITY (Little sore arm). On 05-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced JOINT SWELLING (Hip is so inflamed), GAIT DISTURBANCE (She could hardly walk), FEELING ABNORMAL (Felt terrible), INFLAMMATION (Right hip is so inflamed) and ARTHRALGIA (Pain in hip). At the time of the report, JOINT SWELLING (Hip is so inflamed), GAIT DISTURBANCE (She could hardly walk), FEELING ABNORMAL (Felt terrible), INFLAMMATION (Right hip is so inflamed) and ARTHRALGIA (Pain in hip) was resolving and PAIN IN EXTREMITY (Little sore arm) outcome was unknown.            Patient mentioned this is her 6th week of having a little pain in hip but is better now. Concomitant medication list was not provided. Treatment information was not provided.    This case was linked to MOD-2021-074727 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Hip is so inflamed; She could hardly walk; Felt terrible; Right hip is so inflamed; Pain in hip; Little sore arm; This spontaneous case was reported by a consumer and describes the occurrence of JOINT SWELLING (Hip is so inflamed), GAIT DISTURBANCE (She could hardly walk), FEELING ABNORMAL (Felt terrible), INFLAMMATION (Right hip is so inflamed) and PAIN IN EXTREMITY (Little sore arm) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029A21A and 042L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In February 2021, the patient experienced PAIN IN EXTREMITY (Little sore arm). On 05-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced JOINT SWELLING (Hip is so inflamed), GAIT DISTURBANCE (She could hardly walk), FEELING ABNORMAL (Felt terrible), INFLAMMATION (Right hip is so inflamed) and ARTHRALGIA (Pain in hip). At the time of the report, JOINT SWELLING (Hip is so inflamed), GAIT DISTURBANCE (She could hardly walk), FEELING ABNORMAL (Felt terrible), INFLAMMATION (Right hip is so inflamed) and ARTHRALGIA (Pain in hip) was resolving and PAIN IN EXTREMITY (Little sore arm) outcome was unknown.            Patient mentioned this is her 6th week of having a little pain in hip but is better now. Concomitant medication list was not provided. Treatment information was not provided.    This case was linked to MOD-2021-074727 (Patient Link).
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Pain, Pyrexia, Throat tightness
Clinical narrative: feel shooting pain from knees and wrists; arm was very soar; fever; joints were achy; horrible headache; her throat was a little tight; This spontaneous case was reported by a consumer and describes the occurrence of THROAT TIGHTNESS (her throat was a little tight), PAIN (feel shooting pain from knees and wrists), VACCINATION SITE PAIN (arm was very soar), HEADACHE (horrible headache) and PYREXIA (fever) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced THROAT TIGHTNESS (her throat was a little tight) and HEADACHE (horrible headache). On 10-Apr-2021, the patient experienced PAIN (feel shooting pain from knees and wrists), VACCINATION SITE PAIN (arm was very soar), PYREXIA (fever) and ARTHRALGIA (joints were achy). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) ongoing since an unknown date at a dose of UNK dosage form. On 13-Apr-2021, THROAT TIGHTNESS (her throat was a little tight), PAIN (feel shooting pain from knees and wrists), VACCINATION SITE PAIN (arm was very soar), HEADACHE (horrible headache), PYREXIA (fever) and ARTHRALGIA (joints were achy) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       On 09-APR-2021, within minutes of receiving the vaccine patient said she had horrible headache and her throat was little tight but nurse said just anxiety. No relevant concomitant medications were reported.  Treatment medicine include Advil  Action taken with mRNA-1273 in response to the event was unknown
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: feel shooting pain from knees and wrists; arm was very soar; fever; joints were achy; horrible headache; her throat was a little tight; This spontaneous case was reported by a consumer and describes the occurrence of THROAT TIGHTNESS (her throat was a little tight), PAIN (feel shooting pain from knees and wrists), VACCINATION SITE PAIN (arm was very soar), HEADACHE (horrible headache) and PYREXIA (fever) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced THROAT TIGHTNESS (her throat was a little tight) and HEADACHE (horrible headache). On 10-Apr-2021, the patient experienced PAIN (feel shooting pain from knees and wrists), VACCINATION SITE PAIN (arm was very soar), PYREXIA (fever) and ARTHRALGIA (joints were achy). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) ongoing since an unknown date at a dose of UNK dosage form. On 13-Apr-2021, THROAT TIGHTNESS (her throat was a little tight), PAIN (feel shooting pain from knees and wrists), VACCINATION SITE PAIN (arm was very soar), HEADACHE (horrible headache), PYREXIA (fever) and ARTHRALGIA (joints were achy) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       On 09-APR-2021, within minutes of receiving the vaccine patient said she had horrible headache and her throat was little tight but nurse said just anxiety. No relevant concomitant medications were reported.  Treatment medicine include Advil  Action taken with mRNA-1273 in response to the event was unknown
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: second dose of vaccine >42 days; This spontaneous case was reported by a health care professional and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (second dose of vaccine >42 days) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Jan-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (second dose of vaccine >42 days). At the time of the report, PRODUCT DOSE OMISSION ISSUE outcome was unknown. Not Provided.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment and concomitant medicines were not included.  Action taken with mRNA-1273 in response to the event was unknown.    Nurse asked does patient need to start over the regiment, or just inject the second dose.
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Hyperhidrosis, Suspected COVID-19
Clinical narrative: covid like symptoms; Sweating; This spontaneous case was reported by a consumer and describes the occurrence of SUSPECTED COVID-19 (covid like symptoms) and HYPERHIDROSIS (Sweating) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced SUSPECTED COVID-19 (covid like symptoms) and HYPERHIDROSIS (Sweating). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, SUSPECTED COVID-19 (covid like symptoms) and HYPERHIDROSIS (Sweating) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-Apr-2021, COVID-19: positive (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       no concomitant medications are provided.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling face, Throat irritation
Clinical narrative: Throat scratchy; Swollen under the cheek; This spontaneous case was reported by a consumer and describes the occurrence of THROAT IRRITATION (Throat scratchy) and SWELLING FACE (Swollen under the cheek) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038B21A) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: Vitamin C. Past adverse reactions to the above products included Allergic reaction with Vitamin C. Concomitant products included PROGESTERONE (PROGESTIN) for Birth control, LEVOTHYROXINE for an unknown indication.    On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Apr-2021, the patient experienced THROAT IRRITATION (Throat scratchy) and SWELLING FACE (Swollen under the cheek). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, THROAT IRRITATION (Throat scratchy) and SWELLING FACE (Swollen under the cheek) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Pyrexia, Somnolence
Clinical narrative: was sleeping all day; chills; headache; fever; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (was sleeping all day), CHILLS (chills), HEADACHE (headache) and PYREXIA (fever) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 11-Apr-2021, the patient experienced SOMNOLENCE (was sleeping all day). 11-Apr-2021, the patient experienced CHILLS (chills), HEADACHE (headache) and PYREXIA (fever). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at a dose of UNK dosage form. On 12-Apr-2021, SOMNOLENCE (was sleeping all day), CHILLS (chills), HEADACHE (headache) and PYREXIA (fever) had resolved.            No relevant concomitant medications were reported.  Treatment medicine include Tylenol  Action taken with mRNA-1273 in response to the event was not applicable   This case was linked to US-MODERNATX, INC.-MOD-2021-074732 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Feeling hot, Fungal infection, Injection site pain, Injection site rash
Clinical narrative: Both of my upper arms feel like it's hot on the inside; Yeast infection under my breasts; My face & neck red turned red; Rash at the injection site; My arm was sore; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of FUNGAL INFECTION (Yeast infection under my breasts), FEELING HOT (Both of my upper arms feel like it's hot on the inside), ERYTHEMA (My face & neck red turned red), INJECTION SITE RASH (Rash at the injection site) and INJECTION SITE PAIN (My arm was sore) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Rosacea and Psoriasis.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Mar-2021, the patient experienced INJECTION SITE PAIN (My arm was sore). On 26-Mar-2021, the patient experienced INJECTION SITE RASH (Rash at the injection site). On 30-Mar-2021, the patient experienced ERYTHEMA (My face & neck red turned red). On 02-Apr-2021, the patient experienced FUNGAL INFECTION (Yeast infection under my breasts). On 08-Apr-2021, the patient experienced FEELING HOT (Both of my upper arms feel like it's hot on the inside). At the time of the report, FUNGAL INFECTION (Yeast infection under my breasts), FEELING HOT (Both of my upper arms feel like it's hot on the inside), ERYTHEMA (My face & neck red turned red), INJECTION SITE RASH (Rash at the injection site) and INJECTION SITE PAIN (My arm was sore) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Concomitant medications were not reported.  No treatment details were provided
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy
Clinical narrative: Pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Pregnant) in a 32-year-old female patient  who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) from 09-Jan-2021 to an unknown date for Pregnancy.   On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. The patient's last menstrual period was on 27-Nov-2020 and the estimated date of delivery was 27-Aug-2021. On an unknown date, the patient experienced EXPOSURE DURING PREGNANCY (Pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  fifteenth week of the pregnancy.  At the time of the report, EXPOSURE DURING PREGNANCY (Pregnant) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 04-May-2021: No specific follow-up information recorded.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose, Fatigue, Headache, Malaise
Clinical narrative: not feeling well; Headache; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (not feeling well), HEADACHE (Headache) and FATIGUE (Fatigue) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     Concurrent medical conditions included Type 1 diabetes mellitus (Type 1 diabetes mellitus). Concomitant products included INSULIN for an unknown indication.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, the patient experienced MALAISE (not feeling well), HEADACHE (Headache) and FATIGUE (Fatigue). On 11-Mar-2021, MALAISE (not feeling well) and FATIGUE (Fatigue) had resolved. On 12-Mar-2021, HEADACHE (Headache) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Apr-2021, Blood glucose: 99 (normal) Blood sugar 99 when vomiting..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment details were reported.
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Headache, Myalgia, Pyrexia
Clinical narrative: Little headache; Couldn't breathe; Body ache; High fever; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 12-Mar-2021 and was forwarded to Moderna on 12-Mar-2021.    This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DYSPNOEA (Couldn't breathe), PYREXIA (High fever), MYALGIA (Body ache) and HEADACHE (Little headache) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B12A).) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2021, the patient experienced PYREXIA (High fever). On 08-Apr-2021, the patient experienced MYALGIA (Body ache). On 09-Apr-2021, the patient experienced DYSPNOEA (Couldn't breathe). On 12-Apr-2021, the patient experienced HEADACHE (Little headache). On 10-Apr-2021, DYSPNOEA (Couldn't breathe), PYREXIA (High fever) and MYALGIA (Body ache) had resolved. At the time of the report, HEADACHE (Little headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment included Tylenol, NyQuill pills during mornings and evenings Hot tea. Concomitant medications were not provided.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Feeling cold, Illness, Nausea
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (got really sick), FEELING COLD (felt cold), ARTHRALGIA (achy joints), NAUSEA (nausea) and PYREXIA (slight fever) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007B21A and 040A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Apr-2021, the patient experienced ILLNESS (got really sick), FEELING COLD (felt cold), ARTHRALGIA (achy joints), NAUSEA (nausea), PYREXIA (slight fever) and CHILLS (chills). On 11-Apr-2021, ILLNESS (got really sick), FEELING COLD (felt cold), ARTHRALGIA (achy joints), NAUSEA (nausea), PYREXIA (slight fever) and CHILLS (chills) had resolved. No relevant concomitant medications were reported. No treatment information was provided. Action taken with mRNA-1273 in response to the event was not applicable. This case was linked to MOD-2021-074721, MOD-2021-074721.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (got really sick), FEELING COLD (felt cold), ARTHRALGIA (achy joints), NAUSEA (nausea) and PYREXIA (slight fever) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007B21A and 040A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Apr-2021, the patient experienced ILLNESS (got really sick), FEELING COLD (felt cold), ARTHRALGIA (achy joints), NAUSEA (nausea), PYREXIA (slight fever) and CHILLS (chills). On 11-Apr-2021, ILLNESS (got really sick), FEELING COLD (felt cold), ARTHRALGIA (achy joints), NAUSEA (nausea), PYREXIA (slight fever) and CHILLS (chills) had resolved. No relevant concomitant medications were reported. No treatment information was provided. Action taken with mRNA-1273 in response to the event was not applicable. This case was linked to MOD-2021-074721, MOD-2021-074721.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Urticaria
Clinical narrative: Hives; Hands are swollen; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of URTICARIA (Hives) and PERIPHERAL SWELLING (Hands are swollen) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Apr-2021, the patient experienced URTICARIA (Hives) and PERIPHERAL SWELLING (Hands are swollen). At the time of the report, URTICARIA (Hives) and PERIPHERAL SWELLING (Hands are swollen) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient was not on concomitant medications. The patient went to doctor and doctor said that  events were not related to vaccine and said she had a reaction to something else. Treatment medications included unspecified medication for allergies.  Action taken with mRNA-1273 in response to the event was unknown   Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: Additional information received captured reporter contact details, events outcome and causality.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Insomnia, Lip swelling, Pruritus, Rash
Clinical narrative: itching "really bad"; couldn't sleep; her bottom lip was swollen up; bad rash on her hands, arm, face and under her chin; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PRURITUS (itching "really bad"), INSOMNIA (couldn't sleep), LIP SWELLING (her bottom lip was swollen up) and RASH (bad rash on her hands, arm, face and under her chin) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003AHA) for COVID-19 vaccination.     Concurrent medical conditions included Diabetic. Concomitant products included INSULIN and CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) for an unknown indication.    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, the patient experienced PRURITUS (itching "really bad"), INSOMNIA (couldn't sleep), LIP SWELLING (her bottom lip was swollen up) and RASH (bad rash on her hands, arm, face and under her chin). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of UNK dosage form and PREDNISONE at a dose of UNK dosage form. On 17-Mar-2021, PRURITUS (itching "really bad"), INSOMNIA (couldn't sleep) and LIP SWELLING (her bottom lip was swollen up) had resolved. At the time of the report, RASH (bad rash on her hands, arm, face and under her chin) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient was treated with ice patches.  Concomitant medicines include insulin and Vitamin D  Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to US-MODERNATX, INC.-MOD-2021-074758 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Covid-19 Positive test after the second shot; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 12-Apr-2021 and was forwarded to Moderna on 12-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (Covid-19 Positive test after the second shot) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SARS-COV-2 TEST POSITIVE (Covid-19 Positive test after the second shot). At the time of the report, SARS-COV-2 TEST POSITIVE (Covid-19 Positive test after the second shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported.   This case was linked to MOD21-074146 (E2B Linked Report).; Sender's Comments:  MOD21-074146:
Sex: M
Vaccine: COVID19
Symptoms: Bacterial infection, Chills, Surgery
Clinical narrative: bacterial infection; minor sinus surgery; chills; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of BACTERIAL INFECTION (bacterial infection), SURGERY (minor sinus surgery) and CHILLS (chills) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Sinus operation (Patient had a minor sinus surgery 3 weeks ago and picked up a bacterial infection after on an unspecified date. had chills,  ear-nose-throat (ENT) doctor prescribed him with amoxicillin to take for 5 days).    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced BACTERIAL INFECTION (bacterial infection), SURGERY (minor sinus surgery) and CHILLS (chills). The patient was treated with AMOXICILLIN for Bacterial infection, at a dose of UNK dosage form. At the time of the report, BACTERIAL INFECTION (bacterial infection), SURGERY (minor sinus surgery) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment medication include amoxicillin.  Action taken with mRNA-1273 in response to the event was unknown   Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: Additional information received captured reporter contact details.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: rashes appearing on the left upper arm; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rashes appearing on the left upper arm) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, the patient experienced RASH (rashes appearing on the left upper arm). At the time of the report, RASH (rashes appearing on the left upper arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use included unspecified blood thinners. No treatment information was provided. Action taken with mRNA-1273 in response to the event was unknown